Oxybutynin, a common drug to manage overactive bladder, may help alleviate hot flash symptoms among men receiving androgen deprivation therapy for prostate cancer.

AskBio Inc., an RTP-based gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, has received U.S. Food and Drug Administration (FDA) acceptance of its ...